Béres won the MagyarBrands Award in three categories – interview with Marcell Béres
In 2025, Béres Pharmaceuticals once again received industry recognition, winning the MagyarBrands Award in three categories. The award reflects not only the company’s past performance but also long-term strategic direction. We spoke with Marcell Béres, President of Béres Pharmaceuticals, about what these distinctions mean from the perspectives of brand building, development, and business operations.
It is clear, even from close up, how responsibly the company engages with consumers and how much emphasis it places on maintaining customer trust. What do you think contributed to Béres winning the MagyarBrands Award in the consumer category?
I believe our success among consumers can be attributed to several factors: our distinctive heritage, our long-term perspective, our highly cohesive team of professionals, and the scientific rigour underpinning all of these, which ensures the consistently high quality of our products. I am convinced that consumers recognise that, for us, quality is not simply a marketing claim, but a core principle.
Forward-looking thinking and the pursuit of new solutions have long played a defining role in the company’s operations. What does innovation mean to the company?
We continuously monitor evolving consumer needs, the latest scientific evidence, innovations emerging from our professionals and business partners, and international market trends, while identifying product development areas where we can deliver genuine added value. Our goal is to develop innovative products that meet the highest professional standards and offer more convenient, personalised and effective solutions.
We aim to introduce products that are not only commercially relevant or aligned with current trends, but that also actively contribute to the effective prevention and treatment of widespread diseases. Beyond product innovation, we seek to maintain a competitive edge in packaging, marketing communications, as well as across our organisational, technological and logistics capabilities.
The results of recent years suggest that strategic decision-making and deliberate, long-term development provide a solid foundation for the company. How do you assess the company’s current business performance, and what are your future goals?
Béres is often cited as a Hungarian success story. At the same time, competition in the health protection and selfcare market has intensified driven in part by the rapid and largely unregulated influx of food supplements. A particularly concerning trend is the spread of misleading communications, enabled by gaps in EU regulation and enforcement, which has created a challenging operating environment and, at times, a short-term competitive disadvantage for responsible manufacturers.
At the same time, it is encouraging that many people value Béres’ long-term, professional approach, and that we continue to hold a stable market-leading position, including among younger audiences. Products such as Béres Drops, Actival, Béres Vitamin C products, Porcerő and Szemerő, for example, are among the most popular in their respective categories.
In the domestic market, our goal is to further consolidate our leadership through ongoing product innovation and the expansion of our professional partnerships. As an agile pharmaceutical manufacturer meeting international quality standards, we also aim to take our international presence to the next level.
Our long-term ambition is to preserve family ownership while, through disciplined, strategic growth, developing into an even more influential pharmaceutical player at the regional level.